Latest Articles

Article Type

You have access
MDPV high-responder phenotype as a tool to evaluate candidate medications for stimulant use disorder
Michelle R. Doyle, Lindsey N Peng, Jianjing Cao, Kenner C. Rice, Amy Hauck Newman and Gregory T. Collins

Journal of Pharmacology and Experimental Therapeutics January 10, 2023, JPET-AR-2022-001419; DOI: https://doi.org/10.1124/jpet.122.001419
You have access
Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools
Gaetano Santulli

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 225-226; DOI: https://doi.org/10.1124/jpet.122.001457
You have access
Istaroxime and Beyond: New Therapeutic Strategies to Specifically Activate SERCA and Treat Heart Failure
Roberta Avvisato, Stanislovas S. Jankauskas and Gaetano Santulli

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 227-230; DOI: https://doi.org/10.1124/jpet.122.001446
Open Access
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
Martina Arici, Mara Ferrandi, Paolo Barassi, Shih-Che Hsu, Eleonora Torre, Andrea Luraghi, Carlotta Ronchi, Gwo-Jyh Chang, Francesco Peri, Patrizia Ferrari, Giuseppe Bianchi, Marcella Rocchetti and Antonio Zaza

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 231-244; DOI: https://doi.org/10.1124/jpet.122.001335
You have access
Attenuation of the positive-reinforcing effects of ultra-potent fentanyl analogs, along with those of fentanyl and heroin, during daily treatment with methocinnamox (MCAM) in rhesus monkeys
Lisa R. Gerak and Charles P. France

Journal of Pharmacology and Experimental Therapeutics December 27, 2022, JPET-AR-2022-001267; DOI: https://doi.org/10.1124/jpet.122.001267
You have access
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19
Jessica Gambardella, Urna Kansakar, Celestino Sardu, Vincenzo Messina, Stanislovas S. Jankauskas, Raffaele Marfella, Paolo Maggi, Xujun Wang, Pasquale Mone, Giuseppe Paolisso, Daniela Sorriento and Gaetano Santulli

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 109-115; DOI: https://doi.org/10.1124/jpet.122.001209
Open Access
Identification and Characterization of ACP-5862, the Major Circulating Active Metabolite of Acalabrutinib: Both Are Potent and Selective Covalent Bruton Tyrosine Kinase Inhibitors
Terry Podoll, Paul G. Pearson, Allard Kaptein, Jerry Evarts, Gerjan de Bruin, Maaike Emmelot-van Hoek, Anouk de Jong, Bart van Lith, Hao Sun, Stephen Byard, Adrian Fretland, Niels Hoogenboom, Tjeerd Barf and J. Greg Slatter

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 173-186; DOI: https://doi.org/10.1124/jpet.122.001116
Open Access
The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments
Anetta Wronska

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 123-132; DOI: https://doi.org/10.1124/jpet.121.001152
You have access
Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys
David R. Maguire

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 155-162; DOI: https://doi.org/10.1124/jpet.122.001318
You have access
Regulation of Ferroptosis by Non-Coding RNAs: Mechanistic Insights
Ammad Ahmad Farooqi, Gulnara Kapanova, Sundetgali Kalmakhanov, Abay Z. Kussainov and Zaure Datkhayeva

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 20-27; DOI: https://doi.org/10.1124/jpet.121.001225

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals